26 results on '"Signorelli, C"'
Search Results
2. 529P Evaluating metastatic disease sites as a prognostic marker in patients receiving sequential treatment with regorafenib and trifluridine/tipiracil for refractory colorectal cancer: Survival outcomes from the multicenter retrospective “ReTrITA” study
3. Immunogenicity and early clinical outcome after two or three doses of SARS-CoV-2 mRNA-BNT162b2 vaccine in actively treated cancer patients: results from the prospective observational Vax-On-Third study
4. P-297 Prognostic impact of primary tumor location on synchronous and metachronous colorectal liver metastases: A retrospective monocentric real-life analysis
5. Six month immunogenicity of COVID-19 mRNA-BNT162b2 vaccine in actively treated cancer patients: updated results of the Vax-On study
6. Effects of active cancer treatment on safety and immunogenicity of COVID-19 mRNA-BNT162b2 vaccine: preliminary results from the prospective observational Vax-On study
7. 617P Predictive and prognostic impact of primary tumor location on sequential treatment with regorafenib and trifluridine/tipiracil at third line and beyond in metastatic colorectal cancer: A real-world multicenter retrospective analysis
8. P-368 Efficacacy of trifluridine/tipiracil according to extended RAS evaluation: A multicenter retrospective analysis
9. P-360 Efficacy of regorafenib according to extended RAS evaluation: A multicenter retrospective analysis
10. P-249 Aflibercept-based and bevacizumab-based second-line regimens in patients with RAS/BRAF wild type metastatic colorectal cancer: Propensity score weighted-analysis from a multicenter cohort
11. P-236 Aflibercept-based and bevacizumab-based second-line regimens in patients with RAS mutant metastatic colorectal cancer: Propensity score weighted-analysis from a multicenter cohort
12. P-195 Influence of age on disease control rate of patients treated with regorafenib and trifluridine/tipiracil in refractory metastatic colorectal cancer: A multicenter retrospective real-world study
13. Impact of previous corticosteroid (CS) exposure on efficacy of programmed cell death-(Ligand) 1 blockade in patients with advanced non-small cell lung cancer (NSCLC): A single center retrospective analysis
14. Access of the oncologic patients to the emergency room of the local hospital during the three-year period 2014–2016
15. 1260P - Impact of previous corticosteroid (CS) exposure on efficacy of programmed cell death-(Ligand) 1 blockade in patients with advanced non-small cell lung cancer (NSCLC): A single center retrospective analysis
16. The predictive role of peripheral blood lymphocytes (PBLs) immunophenotype in patients with advanced non-small-cell lung cancer (NSCLC) and renal-cell carcinoma (mRCC) undergoing nivolumab: preliminary results
17. Treatment in advanced malignant pleural mesothelioma after chemotherapy standard
18. A mono institutional retrospective analysis on the safety and efficacy of first-line Folfiri or Folfox (CT) plus bevacizumab (B) in young and elderly patients with metastatic colorectal cancer (MCC)
19. Ante mortem diagnosis of intracardiac metastases from known esophageal cancer: a case report and literature review
20. T23 - Access of the oncologic patients to the emergency room of the local hospital during the three-year period 2014–2016
21. Treatment (T) of Metastatic Colorectal Cancer (Mcrc) Patients (Pts) ≥75 Years (Y) Old in Clinical Practice: a Multicenter Analysis
22. A40 - Treatment in advanced malignant pleural mesothelioma after chemotherapy standard
23. A33 - The predictive role of peripheral blood lymphocytes (PBLs) immunophenotype in patients with advanced non-small-cell lung cancer (NSCLC) and renal-cell carcinoma (mRCC) undergoing nivolumab: preliminary results
24. 600P - Treatment (T) of Metastatic Colorectal Cancer (Mcrc) Patients (Pts) ≥75 Years (Y) Old in Clinical Practice: a Multicenter Analysis
25. 18P Clinical outcomes in pT4N0 colon cancer (CC) patients: Data from a large, multicenter, real-word cohort.
26. Effects of active cancer treatment on safety and immunogenicity of COVID-19 mRNA-BNT162b2 vaccine: preliminary results from the prospective observational Vax-On study
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.